Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 27 (2) , 177-193
- https://doi.org/10.1016/0010-7824(83)90088-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rateContraception, 1982
- Morphometric analysis of the human endometrium in relation to peripheral hormone levelsFertility and Sterility, 1982
- Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μg norethisterone (NET) minipillContraception, 1982
- Pharmacokinetic and pharmacodynamic studies with vaginal devices releasing norethisterone at a constant, near zero orderContraception, 1981
- Hormonal effects of the 300 μg norethisterone (NET) minipillContraception, 1981
- Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroidsContraception, 1978
- Biological and immunological characterization of human luteinizing hormone: II. A comparison of the immunological and biological activities of pituitary extracts after electrofocusing using different standard preparationsMolecular and Cellular Endocrinology, 1977
- A RAPID 5 HOUR RADIOIMMUNOASSAY OF PROGESTERONE AND OESTRADIOL IN HUMAN PLASMAClinical Endocrinology, 1975
- Contraception by means of a Silastic vaginal ring impregnated with medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1970
- Passage of Steroids Through Silicone RubberEndocrinology, 1966